TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Geometric mean ratio of posaconazole AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean ratio of posaconazole C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean ratio of amprenavir AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean ratio of amprenavir C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized incidence of death
Endpoint domain: Mortality/survival
Primary endpoint: Decompensated events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to catheter expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of postpartum depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete analgesia duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective analgesia duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to use hearing aids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk of joint failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 30-day point-prevalence abstinence
Endpoint domain: Mortality/survival
Primary endpoint: Mean bone loss around test implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Grade of toxicity experienced by patients
Endpoint domain: Adverse events/effects
Primary endpoint: Attention difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Memory loss
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cup shape measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cessation of all forms of binge eating and purging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARDS risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bronchospasm incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Chest tightness incidence
Endpoint domain: Adverse events/effects
Primary endpoint: TB diagnostic yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women achieving spontaneous labor before planned induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate specific antigen progression-free survival hazard rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of controls with scars indicating BCG revaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Recurrence Free (LRF) as first event
Endpoint domain: Mortality/survival
Primary endpoint: Complete disappearance of renal colic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average time to 50% improvement in symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional anodyne treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Increase in vegetable purchase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Selection of white milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in chocolate milk purchase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BII
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: I‐PSS‐QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: biomarkers of blood inflammation, coagulation, endothelial function, oxidative stress, and neuroendocrine stress response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in HRQoL (15D total score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Image variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infra-cardiac counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal pulse oximetry value during endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mortality in patients with NSR
Endpoint domain: Mortality/survival
Primary endpoint: Good neurologic outcome (CPC 1-2, mRS 0-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of grade > or = 2 mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute xerostomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary gland function returning to normal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary revascularization procedures
Endpoint domain: Mortality/survival
Primary endpoint: redislocations
Endpoint domain: Mortality/survival
Primary endpoint: ability to walk
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: range of movement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sustained DFR (SDFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative volume status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working memory capacity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Homocysteine plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Folic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of treatment-emergent nausea
Endpoint domain: Adverse events/effects
Primary endpoint: serum ferritin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: functional recovery outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New-onset linear dysphotopsia
Endpoint domain: Adverse events/effects
Primary endpoint: Pain experienced by the temporal LPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient global assessments of therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in log10 viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Willingness to choose a physician based on technical skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ARNI prescription at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of sodium ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of sodium ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regeneratory PCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: length of ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Major bleeding within 48 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of death, myocardial infarction, or urgent target vessel revascularization within 14 days
Endpoint domain: Mortality/survival
Primary endpoint: nocturnal erections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erectile function (EF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma glutamine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lactulose-mannitol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum IOP increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: number of subjects with clinically important corticosteroid response
Endpoint domain: Adverse events/effects
Primary endpoint: average power at 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average power at maximum power output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: load lifted at 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of NPPV treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of tracheal reintubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity rate of ventilator-associated pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Microtensile Bond Strength (μTBS) to root canal dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported drinks per drinking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hazardous drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binge drinking sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of ventriculostomy infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Primary questionnaire response rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Supplementary questionnaire response rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful treatment based on total mesorectal excision quality and circumferential resection margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NAA level in cingulate gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Creatine level in left basal ganglia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Choline/creatine ratio in left basal ganglia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline to week 4 in numeric rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRA risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: annual incidence of bilateral toxic vision loss
Endpoint domain: Adverse events/effects
Primary endpoint: Mean time to complete disintegration of the new tablets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean gastric emptying times (t50 and t90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: serum concentrations of insulin-like growth factor-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: response to growth hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: psychosocial adaptation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: psychosexual function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete asparagine depletion in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allergic reactions to asparaginase
Endpoint domain: Adverse events/effects
Primary endpoint: Development of anti-asparaginase antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in mean energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NKCC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IFN-γ levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: complete improvement in snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trauma-related symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to study requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for mechanical ventilation during the first week of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Counterclockwise rotation of the palatal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mandibular downward and backward rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diclofenac sodium requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of serious adverse events requiring expedited reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of cardiac transplantation
Endpoint domain: Mortality/survival
Primary endpoint: gait kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total bupivacaine concentration at t=360 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median apparent terminal half-life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceptual threshold t0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause mortality and myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: cardiovascular death and myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Back pain-specific disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: changes in VCG parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensation of warmth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in skin wrinkling scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of patients with no pain treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in individual use of pain treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rates at 2 and 3 years
Endpoint domain: Mortality/survival
Primary endpoint: mean canal transportation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endothelium‐dependent flow‐mediated dilation (FMD) of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of false alarms
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of disconnection
Endpoint domain: Adverse events/effects
Primary endpoint: Tube malpositions
Endpoint domain: Adverse events/effects
Primary endpoint: Compliance during OLV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of intrapulmonary shunting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vacc‐4x‐specific DTHs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proliferative T‐cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: health services use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Flexibility of the hamstring muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in patient-reported measures
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Nux vomica response
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma levels of strychnine and brucine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of drinks per drinking occasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrical pain analgesia onset time (t½kON)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure pain analgesia onset time (t½kON)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic effect quantified by response time increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum triacylglycerol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gene expression of adipokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in internal carotid flow as measured by PI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: predialysis plasma tHcy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FEV1 postexercise fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SMA resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PV and SMA blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Probability of prescribing physical therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MACE missed rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relief of sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional aspect improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: worst pain scores (WPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical pregnancy per embryo transferred
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: live birth delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Primary prevention of cardiac events
Endpoint domain: Mortality/survival
Primary endpoint: regression rates of ovarian cysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent falls
Endpoint domain: Adverse events/effects
Primary endpoint: Complete duct clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat mass decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: clinical healing time of fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-operative restored functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean albuterol FEV(1) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean albuterol forced expiratory flow between 25% and 75% of vital capacity response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: enhanced psychological functions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with ≥1 VT/VF episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with symptoms lasting 10 or more days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPR performance competency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nocturnal urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: nocturnal urinary volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: percentage of total daily urine passed at night
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain after PIVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiovascular death, nonfatal myocardial infarction, and resuscitated cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: fatal or nonfatal myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ISR/G change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year prevalence of parasuicide
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of cicatricial ROP
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative week 1 swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean postoperative month 6 margin to reflex distance 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of skin flora around epidural catheter insertion site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in dysmotility‐like dyspepsia symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes